Pharmalittle: We’re reading about weight loss drug spending, launch prices for medicines, and much more
Top of the morning to you, and a fine one it is. Clear, blue skies and mild breezes…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
FDA drops enforcement against Whoop after it tweaks blood pressure feature
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
FDA approves Colorado’s plan to import cheaper drugs from Canada
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
New proposal would close Medicare drug price negotiation loophole
WASHINGTON — The Trump administration on Friday proposed to change a policy that is designed to prevent drugmakers…
AI Prognosis: Your sepsis algorithm shouldn’t require a time machine
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Lilly shares safety, tolerability data on its next-gen obesity drug
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Revolution Medicines’ pancreatic cancer drug proving hard to get
Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic…
Massachusetts sues UnitedHealthcare, claims $100 million overpayment
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare…
Is death optional? Inside the big business of the longevity movement
BERKELEY, Calif. — On a sunny Thursday morning, around 100 people sat on folding chairs beneath a lawn…